Which drug keeps sinus surgery cleaner? dexmedetomidine vs. nitroglycerin
NCT ID NCT07585201
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested two drugs, dexmedetomidine and nitroglycerin, to see which one better reduces bleeding during functional endoscopic sinus surgery (FESS). 66 adults having elective FESS were randomly assigned to receive one of the drugs to lower blood pressure and improve the surgeon's view. The main goal was to compare surgical field quality and drug costs.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- dexmedetomidine and nitroglycerin
- What this could lead to
- If one drug works better, it could make sinus surgeries safer and cheaper by improving visibility and reducing bleeding.
- What could go wrong
- This is a small, completed study with only 66 participants, so results may not apply to everyone. Both drugs have side effects like low blood pressure or slow heart rate.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
66 people
The number who actually took part.
- Started
-
Sep 2022
- Finished
-
Mar 2023
- Lead sponsor
-
A government agency
The lead sponsor is a government body.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
21 to 60 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Physical status: American Society of Anesthesiologists (ASA) I \& II. * Body Mass Index (BMI): 18.5-30 kg/m2. * Type of operation: elective bilateral FESS. * Type of anesthesia: general anesthesia. Exclusion Criteria: * Patients with known history of allergy to study drugs. * Anticipated difficult intubation. * Advanced hepatic, renal or cardiovascular diseases. * Central nervous system disorder, metabolic disease, and electrolyte imbalance. * Coagulopathies or taking drugs affecting coagulation.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Functional endoscopic sinus surgeries are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Zagazig university
Zagazig, Sharqia Province, 44111, Egypt
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a dissolvable bone wax curb bleeding during spine fusion?
- Can a slower oxytocin infusion prevent dangerous blood pressure drops in C-Sections?
- Spinal stimulation may tame blood pressure swings after injury
- Can a smart pump prevent dangerous drops in blood pressure during C-Sections?
- Can a Light-Guided device make arterial sticks easier?
- Can a simple pill stabilize blood pressure after spinal cord injury?